Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Editorial for JNV issue on PML.
Natural History of Multiple Sclerosis Symptoms
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Metabolic features of the cell danger response.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Arzerra receives approval in Japan
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats.
Pages
« first
‹ previous
…
141
142
143
144
145
146
147
148
149
…
next ›
last »